Your browser doesn't support javascript.
loading
Coronavirus helicases: attractive and unique targets of antiviral drug-development and therapeutic patents.
Spratt, Austin N; Gallazzi, Fabio; Quinn, Thomas P; Lorson, Christian L; Sönnerborg, Anders; Singh, Kamal.
Affiliation
  • Spratt AN; Bond Life Sciences Center, University of Missouri, Columbia, MO, USA.
  • Gallazzi F; Bond Life Sciences Center, University of Missouri, Columbia, MO, USA.
  • Quinn TP; Department of Chemistry, University of Missouri, Columbia, MO, USA.
  • Lorson CL; cDepartment of Biochemistry, University of Missouri, Columbia, MO, USA.
  • Sönnerborg A; Bond Life Sciences Center, University of Missouri, Columbia, MO, USA.
  • Singh K; dDepartment of Veterinary Pathobiology, University of Missouri, Columbia, MO, USA.
Expert Opin Ther Pat ; 31(4): 339-350, 2021 Apr.
Article in En | MEDLINE | ID: mdl-33593200

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / Viral Nonstructural Proteins / RNA Helicases / Drug Development / SARS-CoV-2 / COVID-19 Drug Treatment / Methyltransferases Limits: Humans Language: En Journal: Expert Opin Ther Pat Journal subject: TERAPEUTICA Year: 2021 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / Viral Nonstructural Proteins / RNA Helicases / Drug Development / SARS-CoV-2 / COVID-19 Drug Treatment / Methyltransferases Limits: Humans Language: En Journal: Expert Opin Ther Pat Journal subject: TERAPEUTICA Year: 2021 Document type: Article Affiliation country: